EysuvisActive Ingredient(s): Loteprednol Etabonate
FDA Approved: * October 26, 2020
Pharm Company: * KALA PHARMS INC
Category: Allergies, Cough & Cold
Loteprednol (as the ester loteprednol etabonate) is a corticosteroid used to treat inflammations of the eye. It is marketed by Bausch and Lomb as Lotemax and Loterex. It was patented in 1980 and approved for medical use in 1998. Contents 1 Medical uses 2 Contraindications 3 Adverse effects 4 Interactions 5 Pharmacology 5.1 Mechanism of action 5.2 Pharmacokinetics 5.3 Retrometabolic drug design 6 Chemistry 6.1 Chemical synthesis 7 References 8 Furt... [wikipedia]* May have multiple approval dates, manufacturers, or labelers.